Quantum-machine-assisted drug discovery

Area of Science:

• Computational chemistry
• Quantum computing applications
• Pharmaceutical sciences

Background:

• Traditional drug discovery is a lengthy and costly process.
• Computer-aided drug design (CADD) methods have limitations.
• There is a need for accelerated and more efficient drug development workflows.

Purpose of the Study:

• To examine the integration of quantum computing in drug discovery.
• To explore how quantum computing can enhance decision-making in drug development.
• To identify specific quantum approaches for key stages of the drug development cycle.

Main Methods:

• Review of quantum computing algorithms for molecular simulation.
• Analysis of quantum approaches for predicting drug-target interactions.
• Exploration of quantum optimization techniques for clinical trial design.

Main Results:

• Quantum computing offers potential for highly accurate molecular simulations.
• Quantum methods can improve the prediction of drug-target binding affinities.
• Optimization of clinical trial parameters using quantum algorithms is feasible.

Conclusions:

• Integrating quantum computing can accelerate drug discovery timelines.
• Quantum computing has the potential to reduce the overall cost of drug development.
• The application of quantum computing promises to enhance efficiency and benefit public health through faster access to novel therapies.